Resources / NITAG documentation

Evidence to Recommendations and proposed recommendations for use of virus-like particle chikungunya vaccine among adolescent and adult travelers

Download:

Abstract

Policy question 

Should CHIK-VLP be recommended for use in persons aged ≥12 years traveling to areas with risk of chikungunya virus transmission

  • Background paper
  • Americas
  • United States of America
  • EtR framework
  • Chikungunya
Loading...